Idelalisib plus rituximab is effective in systemic AL amyloidosis secondary to chronic lymphocytic leukaemia
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Federica Frezzato Livio Trentin Andrea Visentin Francesco Piazza |
| Publication date | October 3, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |